IMRN - Immuron Ltd ADR logo

IMRN

Immuron Ltd ADR

Revenue grew 100% of years5Y
Hold

Immuron Ltd is a biopharmaceutical company that develops and commercializes polyclonal antibodies. It offers Travelan, an OTC medicine to prevent travelers' diarrhea, and Protectyn, an immune supplement, along with several therapeutics in clinical trials.

⚕️ Healthcare NASDAQ Listed 2017 $ AUD
$1,000 invested 5 years ago $227today

Score Overview

1 Year
Score
Net Growth-62.97%
Net TrendShrank
Net Income Consistency
Rev Growth78.96%
Rev TrendGrew
Revenue Consistency
5 Years
Score5.6
Net Growth-1.39%
Net Trend40%
Net Income Consistency
Rev Growth89x
Rev TrendEvery year
Revenue Consistency
All Time
Score
Net Growth-24.93%
Net Trend44%
Net Income Consistency
Rev Growth9x
Rev Trend89%
Revenue Consistency

See the full market ranking →

Immuron Ltd ADR fundamental performance

Between 2020 and 2025, revenue grew from $ 2M to $ 7M and net income went from -$ 2M to -$ 5M. Revenue increased in every one of those 5 years; net income in 2.

Across Immuron Ltd ADR's full reported history, from 2017 to 2025, revenue grew from $ 1M to $ 7M and net income went from -$ 6M to -$ 5M. Revenue increased in 89% of the years measured; net income in 44%.

Immuron Ltd ADR currently holds a 5-year HDB Score of 5.6 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 1.10
1 Year2025-08-12
$ 1.71-35.64%
5 Years2021-05-27
$ 4.85-77.31%
All Time2017-06-09
$ 8.36-86.83%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 13M-$ 8M$ 9M
2025$ 7M-$ 5M$ 5M
2024$ 4M-$ 6M$ 11M
2023$ 1M-$ 3M$ 18M
2022$ 765.19K-$ 2M$ 22M
2021$ 145.78K-$ 8M$ 25M
2020$ 2M-$ 2M$ 3M
2019$ 2M-$ 4M$ 5M
2018$ 1M-$ 3M$ 4M
IPO2017$ 1M-$ 6M$ 3M

Explore beyond IMRN

You're looking at Immuron Ltd ADR. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies